McKesson Corporation

Valuation Analysis

About the Company

McKesson Corporation en bref

McKesson Corporation (MCK) is currently trading at 655,63 € with a market capitalization of 76,8 Md €. The trailing P/E ratio stands at 19.56x, with a forward P/E of 14.92x. The 52-week range spans from 555,89 € to 871,80 €; the current price is 24.8% below the yearly high. Year-over-year revenue growth stands at +6.0%. The net profit margin stands at 1.18%.

💰 Dividende

McKesson Corporation pays an annual dividend of 2,86 € per share, representing a yield of 0.44%. The payout ratio stands at 8.26%.

📊 Avis des analystes

15 analystes évaluent McKesson Corporation (MCK) au consensus : Achat Fort. L'objectif de cours moyen est de 821,54 €, soit un potentiel de +25.3% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 708,61 € à 929,40 €.

McKesson Corporation : la thèse d'investissement en détail

McKesson Corporation (MCK) operates in the Healthcare — specifically Medical Distribution — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Earnings growth of 37.2% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. Wall Street consensus sits at Strong Buy with an average price target implying roughly 25.3% upside from current levels — analyst sentiment is firmly constructive.

Le scénario baissier

With a net margin of just 1.18%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss.

À surveiller

• The forward P/E of 14.92x is meaningfully below the trailing 19.56x — analysts expect earnings to step up; the next earnings release is the test.
• The analyst consensus price target implies 25.3% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to relatively defensive market behavior.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy McKesson Corporation?

Compare top-rated brokers — low fees, trusted providers, fully regulated.